{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T11:55:03Z","timestamp":1790682903628,"version":"4.1.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,10,1]],"date-time":"2003-10-01T00:00:00Z","timestamp":1064966400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2003,10]]},"DOI":"10.1378\/chest.124.4.1242","type":"journal-article","created":{"date-parts":[[2003,10,10]],"date-time":"2003-10-10T23:11:34Z","timestamp":1065827494000},"page":"1242-1249","source":"Crossref","is-referenced-by-count":124,"title":["Posttransplant Lymphoproliferative Disorder"],"prefix":"10.1016","volume":"124","author":[{"given":"B. Diane","family":"Reams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Page","family":"McAdams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David N.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P.","family":"Steele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Duane","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1378\/chest.124.4.1242_bib1","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1378\/chest.116.5.1273","article-title":"A low incidence of posttransplant lymphoproliferative disorder in 109 lung transplant recipient","volume":"116","author":"Levine","year":"1999","journal-title":"Chest"},{"key":"10.1378\/chest.124.4.1242_bib2","first-page":"214","article-title":"Pretransplantation seronegative Epstein-Barr virus status is the primary risk factor to posttransplantation lymphoproliferative disorder in adult heart, lung, and other solid organ transplantations","volume":"14","author":"Walker","year":"1995","journal-title":"J Heart Lung Transplant"},{"key":"10.1378\/chest.124.4.1242_bib3","first-page":"877","article-title":"Posttransplant lymphoproliferative disease in thoracic organ transplant patients: ten years of cyclosporine-based immunosuppression","volume":"10","author":"Armitage","year":"1991","journal-title":"J Heart Lung Transplant"},{"key":"10.1378\/chest.124.4.1242_bib4","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1164\/ajrccm.154.6.8970360","article-title":"Post-transplant lymphoproliferative disorder in Epstein-Barr virus na\u00efve lung transplant recipients","volume":"154","author":"Aris","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.124.4.1242_bib5","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S0039-6060(96)80265-0","article-title":"Analysis of Epstein-Barr virus-associated posttransplantation lymphoproliferative disorder after lung transplantation","volume":"119","author":"Montone","year":"1996","journal-title":"Surgery"},{"key":"10.1378\/chest.124.4.1242_bib6","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/infdis\/152.5.876","article-title":"Epstein-Barr virus infections and DNA hybridization studies in post-transplant lymphoma and lymphoproliferative lesions: the role of primary infection","volume":"152","author":"Ho","year":"1985","journal-title":"J Infect Dis"},{"key":"10.1378\/chest.124.4.1242_bib7","doi-asserted-by":"crossref","unstructured":"Swinnen, LJ, Costanzo-Nordin, MR, Fisher, SG, et al Increased incidence of posttransplant lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac transplant recipients. N Engl J Med; 323, 1723-1728","DOI":"10.1056\/NEJM199012203232502"},{"key":"10.1378\/chest.124.4.1242_bib8","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1182\/blood.V86.9.3333.bloodjournal8693333","article-title":"Aggressive treatment for postcardiac transplant lymphoproliferation","volume":"86","author":"Swinnen","year":"1995","journal-title":"Blood"},{"key":"10.1378\/chest.124.4.1242_bib9","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/annonc\/11.suppl_1.S113","article-title":"Humanized anti-CD20 monoclonal antibody (rituximab) in post transplant B-lymphoproliferative disorder: a retrospective analysis on 32 patients","volume":"11","author":"Milpied","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1378\/chest.124.4.1242_bib10","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0168-8278(00)80406-7","article-title":"Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with clonal lymphoproliferative disorders after orthotopic liver transplantation: a report of three cases","volume":"32","author":"Zompi","year":"2000","journal-title":"J Hepatol"},{"key":"10.1378\/chest.124.4.1242_bib11","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1016\/S0140-6736(99)02058-9","article-title":"Treatment of post-transplant lymphoproliferative disease with rituximab monoclonal antibody after lung transplantation","volume":"354","author":"Cook","year":"1999","journal-title":"Lancet"},{"key":"10.1378\/chest.124.4.1242_bib12","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/00007890-200201150-00019","article-title":"Treatment of posttransplant lymphoproliferative disease with rituximab: the remission, the relapse, and the complication","volume":"73","author":"Verschuuren","year":"2002","journal-title":"Transplantation"},{"key":"10.1378\/chest.124.4.1242_bib13","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/00007890-200108150-00036","article-title":"Safety of aerosolized amphotericin B lipid complex in lung transplant recipients","volume":"72","author":"Palmer","year":"2002","journal-title":"Transplantation"},{"key":"10.1378\/chest.124.4.1242_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1046\/j.1365-2559.2000.00895.x","article-title":"The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997","volume":"36","author":"Harris","year":"2000","journal-title":"Histopathology"},{"key":"10.1378\/chest.124.4.1242_bib15","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S1053-2498(01)00314-X","article-title":"Lymphoproliferative disease after lung transplantation: comparison of presentation and outcome of early and late cases","volume":"20","author":"Paranjothi","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1378\/chest.124.4.1242_bib16","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/0011-3840(88)90011-1","article-title":"The diagnosis and treatment of posttransplant lymphoproliferative disorders","volume":"25","author":"Nalesnik","year":"1988","journal-title":"Curr Probl Surg"},{"key":"10.1378\/chest.124.4.1242_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2214\/ajr.171.2.9694455","article-title":"Chest radiography as a predictor of outcome in posttransplant lymphoproliferative disorder in lung transplant recipients","volume":"171","author":"Pickhardt","year":"1998","journal-title":"AJR Am J Roentgenol"},{"key":"10.1378\/chest.124.4.1242_bib18","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/modpathol.3880581","article-title":"Posttransplant lymphoproliferative disorders in lung transplant patients: the Cleveland Clinic experience","volume":"15","author":"Ramalingam","year":"2002","journal-title":"Mod Pathol"},{"issue":"Suppl 2","key":"10.1378\/chest.124.4.1242_bib19","first-page":"S1","article-title":"Mechanism of action of rituximab","volume":"12","author":"Maloney","year":"2001","journal-title":"Anticancer Drugs"},{"key":"10.1378\/chest.124.4.1242_bib20","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJM200109273451315","article-title":"Fatal reactivation of cytomegalovirus infection after the use of rituximab for a post-transplantation lymphoproliferative disorder [letter]","volume":"345","author":"Suzan","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.124.4.1242_bib21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200101043440120","article-title":"Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab [letter]","volume":"344","author":"Dervite","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1378\/chest.124.4.1242_bib22","first-page":"894","article-title":"Fatal viscera varicella-zoster infection following rituximab and chemotherapy treatment in a patient with follicular lymphoma","volume":"85","author":"Bermudez","year":"2000","journal-title":"Haematologica"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216486654?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216486654?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,26]],"date-time":"2020-03-26T00:40:00Z","timestamp":1585183200000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216486654"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,10]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,10]]}},"alternative-id":["S0012369216486654"],"URL":"https:\/\/doi.org\/10.1378\/chest.124.4.1242","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2003,10]]}}}